U.S. Hospitality Stock News

In early June 2026, Super Group (SGHC) declared a regular cash dividend of US$0.05 per share, payable on June 30 to shareholders of record on June 23, bringing total 2026 dividends declared so far to US$0.10 per share. At the same time, Super Group’s exposure to major World Cup betting markets such as South Africa, Germany, the U.K. and Spain has brought fresh focus to how global tournaments can influence its betting and gaming activity. We’ll now examine how Super Group’s World Cup exposure...

This article considers whether Bank of America at US$56.02 is priced for opportunity or already reflects much of its potential, and walks through what the current share price might be indicating about value. The stock has returned 4.1% over the past week, 12.4% over the last 30 days, 0.1% year to date, 29.8% over 1 year and 63.3% over 5 years, which puts recent moves in a different context when lined up against the longer track record. Recent headlines around large U.S. banks have focused on...

Enterprise Products Partners (EPD) is back in focus after reporting record Q1 2026 operating volumes across key midstream segments, supported by strong distributable cash flow, ongoing distribution growth, and continued unit repurchases. See our latest analysis for Enterprise Products Partners. At a share price of $37.25, Enterprise Products Partners has eased slightly over the past week and month yet still carries a strong year to date share price return of 15.83% alongside a 1 year total...

Lovesac (LOVE) has opened Q1 2027 with revenue of US$138.2 million and a loss per share of US$0.76, setting a cautious tone after a profitable Q4 2026. Over recent quarters, revenue has moved between US$138.2 million and US$248.0 million while EPS has swung from a profit of about US$2.19 in Q4 2026 to losses in several other periods. This leaves you with a story of solid sales volumes but uneven profitability. For investors, the key takeaway is that margins remain tight, so the focus now is...

Tariffs are back in the headlines, and that matters for your portfolio. With a 10% global tariff still in force and legal fights dragging on, some US exporters look better placed than others, especially those that rely less on imported inputs and sit on solid balance sheets. This article focuses on large, financially robust companies that could be relatively more resilient if trade tensions persist. Below, you will find 3 stocks from a US Tariff-Resilient Exporters screener that appear...

Wondering if AMETEK at about US$227 per share offers fair value or if the price has run ahead of itself? This article looks at what the current valuation is really telling you. Over the short term the stock is up 0.3% over the last week, while the last month shows a 1.9% decline, and year to date the return stands at 8.6% with a 29.0% return over the past year and 48.3% and 79.3% over the last 3 and 5 years respectively. Recent coverage around AMETEK has focused on its role in the broader...

InterDigital stock snapshot after recent trading move InterDigital (IDCC) has drawn investor interest after a recent move in its share price, with the stock closing at $283.73. This comes alongside revenue of $828.924m and net income of $366.371m. See our latest analysis for InterDigital. The recent 1-day share price return of 2.56% and 7-day gain of 8.86% come after a tougher stretch, with the 90-day share price return down 20.98% even as the 5-year total shareholder return is nearly 3x. If...

Why Novanta Stock Is Drawing Attention Now Novanta (NOVT) is back on many watchlists after recent trading left the stock around $160.53, with returns over the past month and past 3 months standing out against longer term performance. See our latest analysis for Novanta. The recent share price of $160.53 comes after a strong 90 day share price return of 37.49% and a year to date share price return of 44.44%. However, the 3 year total shareholder return is slightly down 5.36%, which suggests...

For investors wondering whether UMB Financial at US$135.37 is still offering value or if most of the easy gains are already behind it, this article walks through what the current price might be implying. The stock shows returns of 4.2% over the last 7 days, 7.1% over the last 30 days, 16.2% year to date, 36.3% over 1 year, 125.3% over 3 years, and 66.3% over 5 years. These figures give useful context before assessing what the current valuation might suggest. Recent coverage of UMB Financial...

Recent commentary highlights that Iron Mountain’s data center and asset lifecycle management businesses delivered strong growth in 2025, reinforcing its position as a REIT focused on both physical and digital infrastructure. This combination of expanding digital infrastructure services and a consistently growing dividend profile is drawing renewed investor attention to Iron Mountain’s hybrid storage and information management model. We’ll now explore how this stronger momentum in Iron...

Wondering if Strategy at US$123.97 is priced for a turnaround or still carrying too much past hype? This article focuses squarely on what the numbers suggest about value. The stock has risen 2.9% over the last 7 days, but is down 30.4% over the past month and down 21.1% year to date, after a 67.6% decline over the past year and a very large gain of about 3x over three years. Recent coverage has highlighted Strategy as a high profile software stock that has attracted attention for its...

Barrick Mining (NYSE:B) reported a 60% reduction in injury rates since 2020. The company recorded a 28% year over year drop in lost time injuries. Barrick highlighted high levels of local hiring, strong procurement from local suppliers, and major community investments. For investors who have been focused on Barrick Mining’s recent share price swings, the latest update on safety and community impact adds another dimension to the NYSE:B story. The stock last closed at $40.2, with a return of...

Guardant Health (GH) is back in focus after the U.S. FDA approved its Guardant360 CDx liquid biopsy as a companion diagnostic for Boehringer Ingelheim’s HERNEXEOS in HER2 mutant advanced non small cell lung cancer. See our latest analysis for Guardant Health. The FDA decision appears to have arrived on top of already strong momentum, with a 30 day share price return of 33.67% and a 1 year total shareholder return of 167.03%, suggesting sentiment has shifted rapidly in Guardant Health’s...

What Matador Resources stock’s recent move might mean for you Matador Resources (MTDR) has seen mixed performance recently, with the stock up year to date but down over the past month and past 3 months, which naturally raises valuation questions for investors. See our latest analysis for Matador Resources. At a share price of $54.05, Matador’s recent 1 day and 7 day share price gains sit against weaker 30 day and 90 day share price returns and a stronger year to date share price return of...

This article examines whether Teladoc Health at US$7.34 is starting to look cheap or still carries more risk than reward, by breaking down what the current price might be implying about the stock. The share price has moved 4.1% over the last week and 8.1% over the last month, with a 4.1% return year to date. The return over 1 year sits at 7.0%, while the stock has fallen 70.5% over 3 years and 95.3% over 5 years. Recent news coverage has focused on Teladoc Health's role in telehealth and...

Wondering whether MasTec at around US$362.97 is still good value after a strong run, or if the easy gains are behind it? This article breaks down what the current price really reflects. The stock has had a mixed short term patch, with the price down 0.3% over the last week and down 14.4% over the last month, yet still up 59.4% year to date and 123.9% over the past year. Recent headlines have focused on MasTec's role in large scale infrastructure and energy transition projects, which has kept...

If you are wondering whether Amgen at around US$355 per share is offering fair value or not, the starting point is to understand what the current price is actually baking in. Over shorter periods, the stock has returned 1.6% over the last week, 5.6% over the last month, 8.4% year to date and 23.9% over the past year, with longer term returns of 69.6% over three years and 74.2% over five years. This hints that the market narrative around the stock has shifted over time. Recent headlines have...

In recent days, Marathon Petroleum has been highlighted for benefiting from tighter global fuel markets after the Strait of Hormuz closure disrupted crude and refined product flows, lifting refining margins. As one of the largest U.S. refiners with growing midstream earnings and an emphasis on capital returns, the company is drawing increased investor attention amid concerns about aviation and diesel fuel shortages. Next, we’ll examine how tightening global fuel supplies and Marathon’s...

In recent months, Hewlett Packard Enterprise reported second-quarter 2026 sales of US$9,774 million, returned to profitability, raised its full-year 2026 guidance, and continued shareholder returns through buybacks and a US$0.1425 per-share dividend. At the same time, HPE deepened its focus on AI and hybrid cloud with new NVIDIA-powered ProLiant Gen12 servers, a fast-deployed HPE Private Cloud AI installation at S k y Co. Ltd., and a pay-as-you-go GreenLake model aimed at scaling AI...

First Real Estate Investment Trust of New Jersey (OTCPK:FREV.S) has reported Q2 2026 revenue of US$7.6 million and basic EPS of US$0.08, while trailing 12 month figures show revenue of US$29.9 million and basic EPS of US$0.48 against a net profit margin of 11.9%. Over recent quarters, revenue has moved in a tight band around US$7.2 million to US$7.6 million and quarterly basic EPS has ranged from US$0.08 to US$0.15, giving investors a clear view of how top line stability is filtering through...

If you are wondering whether Chipotle Mexican Grill's current share price reflects its true worth, this breakdown will help you separate story from numbers. The stock has risen 9.8% over the past week and is up 0.4% over the last 30 days, yet it is still down 14.0% year to date and has declined 35.8% over the past 12 months. Recent coverage has focused on Chipotle Mexican Grill's share price pullback over the past year and what that means for long term holders, as well as how current market...

Investors may be wondering whether Wells Fargo at around US$83.73 is offering good value right now, or if the easy money has already been made. The stock has returned 2.2% over the past week and 13.9% over the past month, while year to date it is down 12.0%. It sits on a 1 year return of 18.3%, a 3 year return of 113.9% and a 5 year return of 126.2%. Recent headlines have focused on Wells Fargo's ongoing efforts to strengthen its franchise and address past regulatory and operational issues,...

Recent performance snapshot Moderna (MRNA) has seen mixed share performance recently, with the stock edging up about 0.5% in the latest session and gaining roughly 5% over the past week, while the past month and past 3 months are slightly negative. See our latest analysis for Moderna. That recent 5.2% 7 day share price return sits against a much stronger year to date share price return of 61.7%, while the 3 year total shareholder return is down 61.2%. This means near term momentum contrasts...

Recent performance snapshot Sidus Space (SIDU) has been drawing fresh attention after a turbulent stretch for the stock, with a decline of about 14% in the latest session and mixed returns across recent periods. Over the past week the stock fell about 10%, while it is up roughly 16% over the past month and about 81% over the past 3 months. Year to date, the share price is down around 13%, and the 1 year total return is very large at roughly 145%. In contrast, the 3 year total return declined...